BOSS ZHIPIN-W
02076
TME-SW
01698
NTES-S
09999
4
JD HEALTH
06618
5
BIDU-SW
09888
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | ---- | 15.19%9.02B | ---- | 42.28%7.83B | ---- | -61.76%5.51B | ---- |
Profit adjustment | ||||||||||
Revaluation surplus: | ---- | ---- | ---- | ---- | -140.89%-801M | ---- | -56.13%1.96B | ---- | 220.03%4.47B | ---- |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | -141.14%-801M | ---- | -56.39%1.95B | ---- | 220.03%4.47B | ---- |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | --12M | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | 49.92%-619M | ---- | 32.20%-1.24B | ---- | 21.83%-1.82B | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | -329.75%-520M | ---- | 93.87%-121M | ---- | -44.97%-1.97B | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | -400.00%-9M | ---- | -50.00%3M | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | 91.05%-99M | ---- | -852.38%-1.11B | ---- | 115.05%147M | ---- |
Depreciation and amortization: | ---- | ---- | ---- | ---- | 1.90%428M | ---- | 1.69%420M | ---- | 1.98%413M | ---- |
-Depreciation | ---- | ---- | ---- | ---- | -12.43%296M | ---- | -0.59%338M | ---- | 1.80%340M | ---- |
-Amortization of intangible assets | ---- | ---- | ---- | ---- | 12.77%53M | ---- | 17.50%47M | ---- | 11.11%40M | ---- |
-Other depreciation and amortization | ---- | ---- | ---- | ---- | 125.71%79M | ---- | 6.06%35M | ---- | -5.71%33M | ---- |
Special items | ---- | ---- | ---- | ---- | 614.29%144M | ---- | -126.17%-28M | ---- | 305.77%107M | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | ---- | -8.64%8.18B | ---- | 3.24%8.95B | ---- | -0.34%8.67B | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | -200.00%-1M | ---- | 200.00%1M | ---- | 88.89%-1M | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | ---- | -8.64%-88M | ---- | 90.66%-81M | ---- | -263.58%-867M | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | ---- | -92.85%62M | ---- | 321.17%867M | ---- | 86.08%-392M | ---- |
Special items for working capital changes | ---- | ---- | ---- | ---- | 32.90%-1.82B | ---- | -2,007.04%-2.71B | ---- | 115.73%142M | ---- |
Cash from business operations | -13.39%6.49B | -12.32%3.7B | 18.32%7.49B | 7.32%4.22B | -9.90%6.33B | -41.06%3.93B | -6.91%7.03B | 120.96%6.67B | 37.30%7.55B | 39.94%3.02B |
Other taxs | -32.50%-1.28B | -43.24%-530M | 14.55%-963M | 32.36%-370M | 31.07%-1.13B | 19.68%-547M | -2.89%-1.64B | 38.98%-681M | -171.16%-1.59B | -165.08%-1.12B |
Dividend received - operating | 267.65%125M | 135.29%80M | -80.68%34M | -63.83%34M | -18.89%176M | 88.00%94M | 171.25%217M | 25.00%50M | -54.55%80M | -55.56%40M |
Interest received - operating | 27.88%133M | 119.44%79M | -11.11%104M | -46.27%36M | -42.36%117M | -30.21%67M | -25.64%203M | -46.67%96M | -1.09%273M | 190.32%180M |
Interest paid - operating | -39.85%-1.71B | -61.79%-885M | -64.69%-1.22B | -48.64%-547M | 3.39%-742M | 4.42%-368M | 9.11%-768M | 13.68%-385M | 14.65%-845M | 10.80%-446M |
Net cash from operations | -30.91%3.76B | -27.53%2.45B | 14.49%5.45B | 6.13%3.37B | -5.73%4.76B | -44.74%3.18B | -7.75%5.05B | 242.85%5.75B | 25.01%5.47B | 20.81%1.68B |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | 59.03%-472M | 131.79%247M | -306.82%-1.15B | -297.21%-777M | 82.62%557M | 208.24%394M | -52.19%305M | -171.65%-364M | 144.55%638M | -16.86%508M |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | 475.00%30M | 36.36%30M | 61.90%-8M | 100.73%22M |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | 866.30%889M | ---- | 9,100.00%92M | ---- |
Purchase of fixed assets | -27.19%-276M | -5.41%-117M | -63.16%-217M | -52.05%-111M | 26.11%-133M | 28.43%-73M | -48.76%-180M | -131.82%-102M | -0.83%-121M | -22.22%-44M |
Purchase of intangible assets | 28.13%-46M | 31.25%-11M | -10.34%-64M | -45.45%-16M | -11.54%-58M | -22.22%-11M | -33.33%-52M | -50.00%-9M | -69.57%-39M | 0.00%-6M |
Sale of subsidiaries | ---- | ---- | -49.53%535M | ---- | 400.00%1.06B | -80.00%4M | -97.42%212M | --20M | -57.50%8.22B | ---- |
Acquisition of subsidiaries | ---- | ---- | ---3.7B | ---3.39B | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | -91.42%454M | 418.33%311M | 768.80%5.29B | -85.44%60M | -84.15%609M | -76.63%412M | 195.08%3.84B | 1,816.30%1.76B | 341.36%1.3B | -2.13%92M |
Cash on investment | 65.31%-4.9B | 62.04%-854M | -59.80%-14.12B | 60.51%-2.25B | -107.91%-8.84B | -203.03%-5.7B | -155.56%-4.25B | -276.75%-1.88B | 15.24%-1.66B | 25.85%-499M |
Other items in the investment business | -138.85%-1.04B | -164.16%-737M | 63.69%-435M | -89.80%-279M | 69.99%-1.2B | 96.31%-147M | -99,700.00%-3.99B | -132,566.67%-3.98B | 98.28%-4M | 98.70%-3M |
Net cash from investment operations | 54.71%-6.28B | 82.83%-1.16B | -73.28%-13.86B | -32.10%-6.76B | -150.28%-8B | -13.18%-5.12B | -137.98%-3.2B | -6,560.00%-4.52B | -46.88%8.42B | -99.49%70M |
Net cash before financing | 70.12%-2.52B | 137.91%1.28B | -159.51%-8.42B | -74.68%-3.39B | -275.39%-3.24B | -257.51%-1.94B | -86.68%1.85B | -29.58%1.23B | -31.32%13.89B | -88.43%1.75B |
Cash flow from financing activities | ||||||||||
New borrowing | -9.25%10.46B | -48.75%4.27B | 59.22%11.52B | 156.27%8.34B | 416.93%7.24B | 984.67%3.25B | -24.20%1.4B | 733.33%300M | 181.13%1.85B | -67.27%36M |
Refund | -140.73%-7.54B | -157.28%-2.65B | 65.26%-3.13B | 85.55%-1.03B | -115.32%-9.01B | -221.46%-7.13B | 32.53%-4.18B | 42.76%-2.22B | -118.04%-6.2B | -79.98%-3.88B |
Issuance of bonds | 2.40%6.9B | --1.88B | --6.74B | ---- | ---- | ---- | ---- | ---- | --1.92B | --1.92B |
Dividends paid - financing | -4.86%-6.3B | -5.91%-4.26B | -5.11%-6B | -6.48%-4.02B | -3.57%-5.71B | -4.10%-3.78B | -3.57%-5.52B | -4.40%-3.63B | -4.64%-5.33B | -3.36%-3.48B |
Absorb investment income | 106.25%33M | --33M | -98.40%16M | ---- | --1B | --986M | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---723M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | -69.59%2.76B | -123.56%-765M | 238.46%9.07B | 148.45%3.25B | 21.79%-6.55B | -20.04%-6.7B | -7.14%-8.37B | -2.99%-5.58B | -6.68%-7.81B | 0.07%-5.42B |
Effect of rate | -135.19%-127M | 23.48%-88M | 90.02%-54M | 58.78%-115M | -453.59%-541M | -516.42%-279M | -8.38%153M | 226.42%67M | 826.09%167M | -783.33%-53M |
Net Cash | -62.71%242M | 470.71%519M | 106.63%649M | 98.38%-140M | -50.11%-9.79B | -98.55%-8.64B | -207.41%-6.52B | -18.49%-4.35B | -52.90%6.07B | -137.95%-3.67B |
Begining period cash | 13.22%5.1B | 13.22%5.1B | -69.65%4.5B | -69.65%4.5B | -30.04%14.83B | -30.04%14.83B | 41.70%21.2B | 41.70%21.2B | 614.91%14.96B | 614.91%14.96B |
Cash at the end | 2.26%5.21B | 30.16%5.53B | 13.22%5.1B | -28.18%4.25B | -69.65%4.5B | -65.05%5.91B | -30.04%14.83B | 50.55%16.92B | 41.70%21.2B | -4.50%11.24B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.